eliquis apixaban eliquis apixaban eliquis apixaban logo

This information is intended for healthcare professionals based in the UK.

If you are not a healthcare professional in the UK, please click here.

For Prescribing and Adverse Event reporting information, click here.

desk-img mob-img

Patient Information Booklet for Patients on Apixaban for Stroke Prevention in NVAF

Eliquis is indicated for Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NVAF), with one or more risk factors such as prior stroke or transient ischaemic (TIA), age ≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (New York Heart Association Class ≥ II)1

booklet for adult patients with nvaf on eliquis (apixaban) for stroke prevention

Please select the language of the Patient Information Booklet you would like to view below:

This booklet is also available to patients prescribed ELIQUIS via the patient section of the website.

Purple information icon ELIQUIS (apixaban) SmPC

Please click here to access the ELIQUIS SmPC.

Purple information icon ELIQUIS (apixaban) Patient Information Leaflet

Please click here to access the ELIQUIS Patient Information Leaflet.


  1. ELIQUIS® (apixaban) Summary of Product Characteristics.